NEW YORK, NY--(Marketwire - Jan 29, 2013) - IVD companies have been able to translate success in clinical test-making to food safety applications, according to a new report from Kalorama Information. The healthcare market research publisher says there is a 1.6 billion dollar market for microbiologic tests, immunoassays and molecular tests designed to detect threats to the food supply. The finding was made in its new report, "Food Safety Diagnostics, The World Market."
The global food supply faces numerous threats according to the report, most notably bacteria and viruses but also environmental toxins, as well as adulterants, agricultural chemicals, and veterinary drugs. In certain countries. GMO content is also tested for. The global food industry -- including farms and agricultural production sites; distributors; food processors; retail; and food service industry -- relies on product and environmental (work process surfaces and immediate facility) testing programs leveraging IVD products to ensure food safety. Food safety tests are completed by both food industry users and commercial or third-party laboratories specializing in confirmatory and advanced testing.
"IVD manufacturers can expect a relatively open market opportunity in food safety testing," said Emil Salazar, Kalorama analyst and the author of the report. "Food safety diagnostics do not qualify as medical devices or consumer products and are not subject to the regulatory approvals customary in clinical IVD or even veterinary diagnostics markets."
According to the report, this means cost savings for test-makers used to going through FDA protocols as regulatory guidelines relating to food safety testing recommend rather than restrict usage of market-available products. Regional product certification provided by industry associations represents the primary challenge in market acceptance of food safety diagnostic products. Unlike in clinical labs, regulatory pressures on the food industry to expand and reform food safety testing have minimized the importance of test cost relative to test effectiveness, and IVD manufacturers have significant opportunities to compete against microbiology standards in pathogen testing regardless of cost. Lower diversity in food safety threats relative to clinical diseases also allows IVD manufacturers to focus on specific tests by analysts and achieve significantly lower reagent, test kit and assay costs relative to clinical diagnostics.
The report says that molecular diagnostics will have a growing role to play in food safety because of their speed and sensitivity. Polymerase chain reaction (PCR) test kits, reverse transcriptase-PCR (RT-PCR) and hybridization assays are among the molecular technologies that will see implementation. PCR-alternative tests are also utilized.
The full market research study, "Food Safety Diagnostics, The World Market" contains more information on the market including breakouts of the market analysis by testing segment, company profiles and detailed explanation of food safety threats and government activity in this area. The report can be obtained at http://www.kaloramainformation.com/Food-Safety-Diagnostics-7326556/
About Kalorama Information
Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog.